Regenerative medicine and responsible research and innovation: proposals for a responsible acceleration to the clinic

Research output: Contribution to journalArticlepeer-review


This paper asks how regenerative medicine can be examined through the ‘responsible research and innovation’ (RRI) approach which has been developed over the past decade. It describes the drivers to the development of RRI, and then argues for the need to understand innovation itself through drawing on social science analysis rooted in science and technology studies. The paper then identifies a number of highly specific challenges faced by the regenerative medicine field and the implications these have for value creation. It offers a number of examples of how a combined RRI/science and technology studies perspective can identify priority areas for policy and concludes by arguing for a ‘responsible acceleration’, more likely to foster readiness at a time when much of the policy domain is pushing for ever-rapid access to cell therapies.
Original languageEnglish
Pages (from-to)853-864
Number of pages11
Issue number7
Early online date2 Nov 2017
Publication statusE-pub ahead of print - 2 Nov 2017

Bibliographical note

© 2017 Future Science Group. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.

Cite this